AVANOS MEDICAL, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

AVANOS MEDICAL, INC. reported Cash And Cash Equivalents At Carrying Value of $89.80 million for the year ending 2025.

  • AVANOS MEDICAL, INC. showed a decrease of -16.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2011 to 2025), AVANOS MEDICAL, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 346.8%.
  • Historical annual values: Fiscal year 2025: $89.80 million | Fiscal year 2024: $107.70 million | Fiscal year 2023: $87.70 million | Fiscal year 2022: $127.70 million | Fiscal year 2021: $118.50 million | Fiscal year 2020: $111.50 million | Fiscal year 2019: $205.30 million | Fiscal year 2018: $384.50 million | Fiscal year 2017: $219.70 million | Fiscal year 2016: $113.70 million | Fiscal year 2015: $129.50 million | Fiscal year 2014: $149.00 million | Fiscal year 2013: $44.10 million | Fiscal year 2012: $47.90 million | Fiscal year 2011: $20.10 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: